The vaccine, announced earlier this week by Russia’s sovereign wealth fund, claims an “interim efficacy” of 91.4%, from its ongoing phase-3 trials
Indian Daily
Bringing you you the latest news, opinions, headline, stories, trends & more in the country. Browse the site for up to date information on national, regional and world wide happenings from politics, business, economy, finance, sports, movies, lifestyle, travel, events, food and a lot more
